Cell and gene therapies: for biotechs, collaboration is key to successful innovation

Cell and gene therapies are expected to represent one of the biggest advances in medical treatments since the introduction of monoclonal antibodies. And needless to say, there is enormous opportunity in this field for biotech companies. However, the path to developing and commercializing a cell and gene therapy product is complex and there are many hurdles to overcome. Learn more about what to look for in the right CRO partner to overcome logistical and operational challenges.

Previous Video
Genomics & biomarkers: Answers in the blood
Genomics & biomarkers: Answers in the blood

Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP ...

Next Article
Commercial and regulatory strategy considerations for biotech
Commercial and regulatory strategy considerations for biotech

In this blog, Parexel regulatory and strategy experts tackle the question of how we can ensure that worthy ...